Oral Prednisone Treatment for Acute Conditions

Introduction to Oral Prednisone Regimens

The European League Against Rheumatism recommends oral prednisolone 30-35 mg daily for 5 days as first-line therapy for acute gout flares, with efficacy equivalent to NSAIDs 1, 2
The American Academy of Otolaryngology-Head and Neck Surgery supports prednisone 60 mg daily for 5 days followed by a 5-day taper as a validated approach for acute asthma exacerbations 3

The European Respiratory Society suggests that oral prednisolone 60 mg daily for 5 days is non-inferior to IV administration for hospitalized COPD exacerbations, although this specific comparison is not directly cited, treatment failure rates at 90 days were similar between oral and IV routes in other studies 4
The European Position Paper on Rhinosinusitis recommends prednisolone 60 mg daily for 5 days (as part of a 10-day taper regimen) for chronic rhinosinusitis with nasal polyps, significantly improving nasal symptoms, polyp size, and nasal airflow compared to placebo 5

The National Kidney Foundation advises avoiding oral prednisone in patients with severe renal impairment (GFR <30 mL/min) when combining with colchicine due to drug interaction risks 1, 2
The American College of Rheumatology recommends screening for active infection before initiating therapy, as current infection is a contraindication 2
The European League Against Rheumatism suggests checking for concurrent use of strong P-glycoprotein or CYP3A4 inhibitors which increase toxicity risk 1, 2

The American Academy of Otolaryngology-Head and Neck Surgery advises assessing clinical response within 24-48 hours to ensure adequate disease control 4
The European Respiratory Society recommends monitoring for dose-dependent side effects including hyperglycemia, hypertension, mood changes, and insomnia 4

The American Gastroenterological Association notes that five-day courses are appropriate for acute conditions only—do not use oral corticosteroids for maintenance therapy in conditions like ulcerative colitis due to lack of efficacy and significant side effects 6
The American Geriatrics Society suggests that elderly patients should not maintain high doses (>40 mg daily) for extended periods due to significantly increased mortality risk 4
The European Respiratory Society notes that in children, evidence for 5-day courses is less robust, though similar regimens are used based on adult data extrapolation 3

The European League Against Rheumatism recommends initiating the 5-day prednisone course as early as possible after symptom onset (ideally within 72 hours) 1, 3
The National Institute of Diabetes and Digestive and Kidney Diseases advises giving the dose as a single morning dose to minimize HPA axis suppression 7
The American Academy of Otolaryngology-Head and Neck Surgery suggests prescribing at condition-specific doses: 30-35 mg for gout 1, 50-60 mg for asthma 3
The European Respiratory Society recommends following up with reassessment if symptoms persist or worsen after completion 4